Translational Health Sciences

UK’s leading surgeons mark official launch of £21m NIHR Biomedical Research Centre

Almost a third of hospital admissions involve a surgical procedure and with 4.7 million operations carried out in the UK each year and numbers rising year on year, surgery is one of the most important life-saving treatments offered to patients. Innovative surgical procedures are continually being developed but how are they tested to ensure they are safe? Two of the UK’s leading academic surgeons will answer these questions at a public lecture and debate on Thursday 1 February 2018 to mark the official launch of the £21 million National Institute for Health Research (NIHR) Bristol Biomedical Research Centre (BRC).

Powerful new synthetic vaccines to combat epidemics

A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings, published in Science Advances today [Wednesday 25 September], reveal exceptionally promising results for the Chikungunya vaccine candidate, which has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.